Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
Giorgio Bogani, Bradley J. Monk, Matthew A. Powell, et al.
Annals of Oncology (2024) Vol. 35, Iss. 5, pp. 414-428
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Incorporating immune checkpoint inhibitors in epithelial ovarian cancer
Giorgio Bogani, Kathleen Moore, I. L. Ray-Coquard, et al.
Gynecologic Oncology (2025) Vol. 193, pp. 30-40
Closed Access | Times Cited: 3
N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment
Zhiyun Duan, Runhan Shi, Bo Gao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
PD-1 and PD-L1 Expression in Endometrial Cancer: A Systematic Review of the Literature
Orazio De Tommasi, Matteo Marchetti, Marta Tripepi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 401-401
Open Access
Organoid development and applications in gynecological cancers: the new stage of tumor treatment
Yang Li, Meiying Qin, Ning Liu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
Л. А. Таширева, Irina Larionova, N. A. Ermak, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trials
Cecilia Nasso, Silvia Puglisi, Sara Elena Rebuzzi, et al.
Immunotherapy (2025), pp. 1-10
Closed Access
Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis
Ling Zhong, Ying Lin, Chun-Xiao Li, et al.
Journal of Gynecologic Oncology (2025) Vol. 36
Open Access
Towards the Prediction of Responses to Cancer Immunotherapy: A Multi-Omics Review
Weichu Tao, Qian Sun, Bingxiang Xu, et al.
Life (2025) Vol. 15, Iss. 2, pp. 283-283
Open Access
Prognostic Evaluation and Functional Characterization of Cyclin K Expression in Endometrial Cancer: Immunohistochemical and In Silico Analysis
Marcin Szymański, Klaudia Bonowicz, Dominika Jerka, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 792-792
Open Access
Immunotherapy and PARP inhibitors as first-line treatment in endometrial cancer: a systematic review and network meta-analysis
Guillermo Villacampa, Gemma Eminowicz, Víctor M. Navarro, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115329-115329
Closed Access
Efficacy of PD-(L)1 Inhibition in the Treatment of Endometrial Cancer Across Molecular Classes: A Systematic Review and Meta-analysis
Merve Kaya, Marloes Schaddelee, Carien L. Creutzberg, et al.
International Journal of Gynecological Cancer (2025), pp. 101759-101759
Open Access
WRN dependency in dMMR/MSI-H endometrial cancer: Clinical perspectives of a novel synthetic lethality strategy
Giovanni Fucá, Cristian Dell'Acqua, Beatrice Peruffo, et al.
Gynecologic Oncology (2025) Vol. 195, pp. 12-15
Closed Access
Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer
Mohd Nazzary Mamat Yusof, Kah Teik Chew, Nirmala Chandralega Kampan, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0312765-e0312765
Open Access
Underrecognized diagnostic discordance and delay in endometrial dedifferentiated and undifferentiated carcinoma
Saria Kawano, Hiroshi Yoshida, Nao Kikkawa, et al.
Journal of Obstetrics and Gynaecology Research (2025) Vol. 51, Iss. 3
Closed Access
Leveraging microbiome signatures to predict tumor immune microenvironment and prognosis of patients with endometrial carcinoma
Yuting Yang, Yuanlong Meng, Ziyang Xu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
Margherita Ambrosini, Paolo Manca, Vincenzo Nasca, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
The role of nanotechnologies in diagnostics and treatment of female reproductive system cancer
Z. R. Faizullina, A. A. Zhilenko, Almaz Kh. Islamgulov, et al.
Obstetrics Gynecology and Reproduction (2025)
Open Access
Pathological insights into activin A: Molecular underpinnings and therapeutic prospects in various diseases
Sejal Kundra, Rupinder Kaur, Chirag Pasricha, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112709-112709
Closed Access | Times Cited: 4
Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer
Haruka Suzuki, Kohei Hamada, Junzo Hamanishi, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Correspondence on “The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment” by De Vitis et al.
Filippo Alberto Ferrari, Francesco Raspagliesi, Giorgio Bogani
International Journal of Gynecological Cancer (2025), pp. 101751-101751
Closed Access
Upfront and interval debulking surgery in advanced/metastatic endometrial cancer in the era of molecular classification
Fabio Caiazzo, Francesco Raspagliesi, Valentina Chiappa, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2025), pp. 113958-113958
Closed Access
Performance of molecular classification in predicting oncological outcomes of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer
Filippo Alberto Ferrari, Stefano Uccella, Massimo Piergiuseppe Franchi, et al.
International Journal of Gynecological Cancer (2024) Vol. 35, Iss. 1, pp. 100016-100016
Closed Access | Times Cited: 3
Locally advanced and metastatic endometrial cancer: Current and emerging therapies
Alixe Salmon, Alizée Lebeau, Sylvie Streel, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102790-102790
Open Access | Times Cited: 2
Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications
Xiangyu Wang, Yinuo Li, Xin Hou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top